About us
Leading the charge against neurodegenerative diseases through groundbreaking gene therapy innovation
-
About us
Our dedication to research and commitment to neurological health place us at the forefront of science and medicine, with a clear mission: to improve the lives of those facing these devastating conditions.
At Tetraneuron, we believe in a future where neurodegenerative diseases no longer signify relentless suffering and decline. Instead, we envision personalized and effective therapies that bring hope and enhance quality of life. This dream is what drives us to work tirelessly every day. -
Our mission
Our mission is to revolutionize the landscape of neurodegenerative diseases by providing safe and effective gene therapies targeting disorders like Alzheimer's and other aging-related neurodegenerative conditions. We're dedicated to scientific excellence and ethical standards at every stage of our journey. -
Our Experience
At Tetraneuron, our team consists of scientists and biotechnology experts who have dedicated their careers to researching and developing gene therapies for neurodegenerative diseases. With our expertise in neuroscience and technology, we approach complex medical challenges in innovative ways.
Our history
2023
New strategic alliances in Parkinson and aging
2022
Pre-IND meeting with the FDA
2021
Beginning of the preclinical regulatory phase
2020
Methode validation of TET-101
2019
Analysis of biological processes modulated by E2F4DN
2018
Validation of the Leading Compound
2017
Validation of the Leading Compound
2016
Identification of the Leading Compound
2015
Validation of the therapeutical target E2F4DN
2014
Beginning of the proof of concept
2013
Identification of the therapeutical target E2F4
2012
Tetraneuron was founded
Tetraneuron es una empresa biotecnológica española de terapia génica centrada en las enfermedades cerebrales y neurodegenerativas
Con sede en Madrid y Valencia, Tetraneuron nace como spin-off del Instituto Cajal, perteneciente al Consejo Superior de Investigaciones Científicas (CSIC)
Comprometidos con la excelencia científica y la ética en cada paso del camino.
Our team
Álvaro Pascual-Leone. MD.PhD
Scientific Board Member
Teodoro del Ser. MD. PhD
Scientific Board Member
David Mor
Board Member
Mari Carmen Álvarez. PhD
Managing Director
Mar Municio. PhD
R&D Director
Noelia López Sánchez. PhD
Technical Director
Cristina Sánchez Puelles. PhD
Senior Researcher
Morgan Ramón Landrau
Researcher
Alberto Garrido
Laboratory Technician
Vanesa Cano
Laboratory Technician
Irene Camacho
PhD. Student
Marika Russo. PhD
Strategic Advisor
Alonso Fernández Nistal, PhD
Strategic Advisor
Ángel Lucio Pereira
Strategic Advisor